Evoke Wealth’s Globus Medical GMED Stock Holding History

Evoke Wealth’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-183	Closed	-$10.8K	–	1228
2019 Q4	$10.8K	Hold	183	–	–	﹤0.01%	724
2019 Q3	$9.35K	Buy	+183	New	+$8.72K	﹤0.01%	840

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Evoke Wealth's GMED Position: Q1 2020 in Review

Evoke Wealth sold out of Globus Medical (GMED) in Q1 2020, closing a stake of 183 shares — an estimated $10.8K sold.

Evoke Wealth first reported a position in GMED in Q3 2019 and held it in 2 quarters. The position peaked at $10.8K in Q4 2019. 273 funds tracked by Wall St. Rank hold GMED as of Q1 2020.

Evoke Wealth reported no remaining Globus Medical position as of Q1 2020 after selling out during the quarter.
Evoke Wealth sold 183 Globus Medical shares in Q1 2020, an estimated $10.8K.
Evoke Wealth first reported a position in Globus Medical in Q3 2019 and held it in 2 quarters.
Evoke Wealth's Globus Medical position peaked at $10.8K in Q4 2019.
273 funds tracked by Wall St. Rank held Globus Medical as of Q1 2020.

Based on Evoke Wealth's 13F filing for Q1 2020, filed 7 May 2020.